Skip to content

Psychophysiological Correlates of Mindfulness Based Cognitive Therapy (MBCT) in Recurrent Depression

Psychophysiological Correlates of Mindfulness and Attention in Recurrent Depression and Healthy Volunteers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00974077
Acronym
MBCT & EEG
Enrollment
120
Registered
2009-09-10
Start date
2008-09-30
Completion date
2011-07-31
Last updated
2014-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Keywords

recurrent depression,, mindfulness training, attention, Evoked EEG potentials, Relapse prevention in recurrent depression

Brief summary

The study investigates cognitive attention, rumination and psychophysiological (EEG) processes in healthy subjects and remitted patients with at least three previous depressive episodes. The investigators expect that Mindfulness Based Cognitive Therapy prevents future depressive episodes and has influence on cognitive and psychophysiological measures.

Interventions

BEHAVIORALMindfulness Based Cognitive Therapy

Group treatment over 8 weeks with training in meditation, stress regulation, shift attention, stay present, in addition with cognitive and behavioral strategies (following Williams et al. Manual 2002)

Patients receive MBCT with a delay of 6 months.

Sponsors

University Hospital Tuebingen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* recurrent depression with at least 3 previous MD-episodes, currently remitted (no symptoms)

Exclusion criteria

* current depression * lifetime schizophrenia * bipolar or schizoaffective disorder * any neurological disorders * other psychopathology during last 3 years

Design outcomes

Primary

MeasureTime frame
Relapse (MDE)12 month

Secondary

MeasureTime frame
Electroencephalography (EEG)6 month

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026